Funding Opportunities for Test Method Developers
NICEATM and ICCVAM seek to facilitate development of test methods that replace, reduce, and refine the use of animals in testing. In addition, both organizations are committed to the protection of human health, animal health, and the environment. This page lists announcements of funding opportunities intended to support the development of alternative test methods. If you are aware of a funding opportunity that could be included on this page, please contact NICEATM.
SBIR and STTR Omnibus Grant Solicitations of the National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration
NIEHS is offering funding for small businesses developing technologies of interest to the Tox21 program. These technologies include:
- Improved or expanded testing methods for toxicity screening
- Computational approaches for predictive toxicology
- Technologies such as alternative or improved methods for fixing and preserving tissues
The funding is being offered as part of the 2020 Omnibus Solicitation of the NIH, CDC, and Food and Drug Administration. This funding is available for small business grant applications to support development and commercialization of innovative technologies. View more information on the NIEHS website.
SBIR/STTR Omnibus Solicitations and Accompanying Resources
- Solicitation notices on NIH website (posted July 14, 2020)
- Program Descriptions and Research Topics
- Application Guide for SBIR/STTR Grant Applications
Next due date: September 8, 2020
For more information about this opportunity, contact:
NIH Funding Resources
The NIEHS SBIR/STTR Program Staff encourages applicants to submit grants at least one week before the deadline and to take advantage of the following resources:
- NIH "All About Grants" Podcast on the Office of Extramural Research website
- NIH RePORTER Matchmaker – useful for an initial screen for matching your technology to an institute and a relevant study section for review. It is also a great place to better understand what types of technologies NIH institutes fund.
- NIH Grants Policy Statement – rules for applying for and accepting a grant
- Frequently Asked Questions about SBIR and STTR grants on the NIH website
- Frequently asked questions about SBIR/STTR grants in general
- Annotated SBIR/STTR SF424 application forms
- Webinar series for funding opportunities for environmental technologies
- NIH study section identifier – allows you to search your topic of interest
- Application cover letters are optional but provide you an opportunity to designate an institute or study section
- Rules for calculating number of employees
- Registration and application instructions (this process can take six to eight weeks and should be initiated well before the deadline)
- Top five eRA Commons errors
NIEHS Offers Commercialization Readiness Pilot Funding
NIEHS has reissued the Funding Opportunity Announcement for its Commercialization Readiness Pilot program. These grants support commercialization of previously funded SBIR and STTR Phase II and Phase IIB projects by funding activities not typically supported through Phase II or Phase IIB grants or contracts. Small businesses that have had an active National Institutes of Health SBIR or STTR Phase II or Phase IIB award within the last 36 months are eligible to apply. Awardees will receive up to $300,000. Standard SBIR/STTR application deadlines apply for these grants; the next deadline is September 8.
NCATS Funding Use of Tissue Chips to Support COVID-19 Research
NCATS has issued two Notices of Special Interest to support research in collecting and examining data on the risks and outcomes for COVID-19 infections using MPS or tissue chips. Such work is expected to advance the translation of research findings into diagnostics, therapeutics, and vaccines. Applications for both opportunities will be accepted on a rolling basis from May 15, 2020, through January 25, 2022.
- NOT-TR-20-016 announces the availability of one-year administrative supplements for investigators and institutions funded through existing grants of the NCATS MPS program. Proposals should address how the work will contribute to advancing translational research for COVID-19.
- NOT-TR-20-017 announces the availability of competitive revisions for investigators and institutions funded through existing grants of the NCATS MPS program. Proposals should address development of MPS models for COVID-19, the use of MPS for rapid detection of COVID-19 infection, or the use of MPS to evaluate potential therapeutics for COVID-19.